Manning-Bog AB - Search Results

1

Decreased expression of the transcription factor NURR1 in dopamine neurons of cocaine abusers.

Bannon MJ, Pruetz B, Manning-Bog AB, Whitty CJ, Michelhaugh SK, Sacchetti P, Granneman JG, Mash DC, Schmidt CJ. Bannon MJ, et al. Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6382-5. doi: 10.1073/pnas.092654299. Epub 2002 Apr 16. Proc Natl Acad Sci U S A. 2002. PMID: 11959923 Free PMC article.

2

Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter.

Manning-Boğ AB, Caudle WM, Perez XA, Reaney SH, Paletzki R, Isla MZ, Chou VP, McCormack AL, Miller GW, Langston JW, Gerfen CR, Dimonte DA. Manning-Boğ AB, et al. Neurobiol Dis. 2007 Aug;27(2):141-50. doi: 10.1016/j.nbd.2007.03.014. Epub 2007 May 3. Neurobiol Dis. 2007. PMID: 17560790

3

Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat.

McCormack AL, Thiruchelvam M, Manning-Bog AB, Thiffault C, Langston JW, Cory-Slechta DA, Di Monte DA. McCormack AL, et al. Neurobiol Dis. 2002 Jul;10(2):119-27. doi: 10.1006/nbdi.2002.0507. Neurobiol Dis. 2002. PMID: 12127150

4

Lack of nigrostriatal pathology in a rat model of proteasome inhibition.

Manning-Boğ AB, Reaney SH, Chou VP, Johnston LC, McCormack AL, Johnston J, Langston JW, Di Monte DA. Manning-Boğ AB, et al. Ann Neurol. 2006 Aug;60(2):256-60. doi: 10.1002/ana.20938. Ann Neurol. 2006. PMID: 16862576

5

Evidence of oxidative stress in young and aged DJ-1-deficient mice.

Raman AV, Chou VP, Atienza-Duyanen J, Di Monte DA, Bellinger FP, Manning-Boğ AB. Raman AV, et al. Among authors: manning bog ab. FEBS Lett. 2013 May 21;587(10):1562-70. doi: 10.1016/j.febslet.2013.04.001. Epub 2013 Apr 13. FEBS Lett. 2013. PMID: 23587484 Free article.

6

Differential contribution of lipoxygenase isozymes to nigrostriatal vulnerability.

Chou VP, Holman TR, Manning-Bog AB. Chou VP, et al. Among authors: manning bog ab. Neuroscience. 2013 Jan 3;228:73-82. doi: 10.1016/j.neuroscience.2012.10.009. Epub 2012 Oct 16. Neuroscience. 2013. PMID: 23079635 Free PMC article.

7

Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration.

Manning-Bog AB, McCormack AL, Purisai MG, Bolin LM, Di Monte DA. Manning-Bog AB, et al. J Neurosci. 2003 Apr 15;23(8):3095-9. doi: 10.1523/JNEUROSCI.23-08-03095.2003. J Neurosci. 2003. PMID: 12716914 Free PMC article.

8

Model fusion, the next phase in developing animal models for Parkinson's disease.

Manning-Bog AB, Langston JW. Manning-Bog AB, et al. Neurotox Res. 2007 Apr;11(3-4):219-40. doi: 10.1007/BF03033569. Neurotox Res. 2007. PMID: 17449461 Review.

9

Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism.

Manning-Boğ AB, Schüle B, Langston JW. Manning-Boğ AB, et al. Neurotoxicology. 2009 Nov;30(6):1127-32. doi: 10.1016/j.neuro.2009.06.009. Epub 2009 Jul 2. Neurotoxicology. 2009. PMID: 19576930

10

Lysosomal degradation of alpha-synuclein in vivo.

Mak SK, McCormack AL, Manning-Bog AB, Cuervo AM, Di Monte DA. Mak SK, et al. Among authors: manning bog ab. J Biol Chem. 2010 Apr 30;285(18):13621-9. doi: 10.1074/jbc.M109.074617. Epub 2010 Mar 3. J Biol Chem. 2010. PMID: 20200163 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters